Current trends in mouse models of glioblastoma Masafumi MiyaiHiroyuki TomitaAkira Hara Topic Review Open access 20 October 2017 Pages: 423 - 432
Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013 Vishesh KhannaRebecca L. AcheyPeter M. de Blank Laboratory Investigation 21 August 2017 Pages: 433 - 441
Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas Jun ThorsteinsdottirStefan StanglChristian Schichor Laboratory Investigation 28 August 2017 Pages: 443 - 452
Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo Xiupeng XuNing CaiNing Liu Laboratory Investigation 30 August 2017 Pages: 453 - 463
Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil Dayane B. KoshiyamaPatrícia TrevisanPaulo R. G. Zen Laboratory Investigation 30 August 2017 Pages: 465 - 472
Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc Sankaradoss ArunShantha RavisankarArambakkam Janardhanam Vanisree Laboratory Investigation 05 September 2017 Pages: 473 - 485
SHP2 regulates proliferation and tumorigenicity of glioma stem cells Laura RoccograndiZev A. BinderDonald M. O’Rourke Laboratory Investigation 29 August 2017 Pages: 487 - 496
Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy Shailendra JoshiJohann R. N. CookeJeffrey N. Bruce Laboratory Investigation 05 September 2017 Pages: 497 - 506
Metastatic melanoma: prognostic factors and survival in patients with brain metastases E. FrintonD. TongR. E. Board Clinical Study Open access 17 August 2017 Pages: 507 - 512
Clinical features and long-term outcomes of primary spinal malignant melanoma: a single center experience Liang WuNing YaoYulun Xu Clinical Study 17 August 2017 Pages: 513 - 519
Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients Dominique FortinDerek TsangDavid C. Hodgson Clinical Study 19 August 2017 Pages: 521 - 528
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma Matthew KoshyDavid J. SherChad Rusthoven Clinical Study 23 August 2017 Pages: 529 - 534
The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma Ryan S. YoulandCole R. KreofskyNadia N. Laack Clinical Study 23 August 2017 Pages: 535 - 543
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma Jay-Jiguang ZhuPetya DemirevaZvi Ram on behalf of the EF-14 Trial Investigators Clinical Study Open access 28 August 2017 Pages: 545 - 552
The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma Xiang LiuRajiv ManglaMahlon D. Johnson Clinical Study 09 September 2017 Pages: 553 - 560
Correlation between arterial spin-labeling perfusion and histopathological vascular density of pediatric intracranial tumors Kazufumi KikuchiAkio HiwatashiHiroshi Honda Clinical Study 30 August 2017 Pages: 561 - 569
Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry Birthe Krogh RasmussenSteinbjørn HansenKim Oren Gradel Clinical Study 31 August 2017 Pages: 571 - 579
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone Nils D. ArvoldDiana D. ShiBrian M. Alexander Clinical Study 03 October 2017 Pages: 581 - 591
Skin toxicities associated with tumor treating fields: case based review Rimas V. LukasKelley L. RatermannJohn L. Villano Clinical Study 28 August 2017 Pages: 593 - 599
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status Rachel L. DelfantiDavid E. PiccioniNikdokht Farid Clinical Study 04 September 2017 Pages: 601 - 609
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status Rachel L. DelfantiDavid E. PiccioniNikdokht Farid Erratum 13 September 2017 Pages: 611 - 611
Resident participation is not associated with postoperative adverse events, reoperation, or prolonged length of stay following craniotomy for brain tumor resection Nikita LakomkinConstantinos G. Hadjipanayis Clinical Study 30 August 2017 Pages: 613 - 619
Estimating progression-free survival in patients with glioblastoma using routinely collected data Charlotte KellyPaulina MajewskaMatt Williams Clinical Study Open access 27 September 2017 Pages: 621 - 627
Role of radiation therapy in primary central nervous system lymphoma Hyeon Kang KohIl Han KimIn Ah Kim Clinical Study 22 September 2017 Pages: 629 - 638
Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy? Kadri Altundag Letter to the Editor 12 September 2017 Pages: 639 - 639
